Brian Concannon

Insider profile

Currently holds a position at Conmed Corp

Performance

Overall performance
3.1

Performance over holding periods
3.1
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 26% 68% 82%
Transactions
10 10% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Conmed Corp July 26, 2013 -
President, Chief Executive Officer, Director Haemonetics Corp April 2, 2009 - Sept. 29, 2015

Brian Concannon's trades of Conmed Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-06-08 2023-06-07 S Sale
88,389 -36.6%
238.55
US$663,326
88,389 -36.6% 238.55 US$663,326
2023-06-07 2023-06-07 PrS Proposed sale
88,782
479.49
US$501,911
88,782 479.49 US$501,911
2023-05-02 2023-05-01 S Sale
48,000 +26.3%
294.62
US$3,515,417
48,000 +26.3% 294.62 US$3,515,417
2023-05-01 2023-05-01 PrS Proposed sale
2,072
125.00
US$259,000
2,072 125.00 US$259,000
2022-02-04 2022-02-02 S Sale
1,843 -17.0%
135.06
US$248,916
1,843 -17.0% 135.06 US$248,916
2022-02-04 2022-02-02 S Sale
2,165 -19.4%
135.08
US$292,448
2,165 -19.4% 135.08 US$292,448
2022-02-04 2022-02-02 S Sale
2,549 -22.1%
135.08
US$344,319
2,549 -22.1% 135.08 US$344,319
2022-02-04 2022-02-02 S Sale
200 -2.2%
137.91
US$27,582
200 -2.2% 137.91 US$27,582
2022-02-04 2022-02-02 S Sale
4,200 -31.3%
136.96
US$575,232
4,200 -31.3% 136.96 US$575,232
2022-02-04 2022-02-02 S Sale
2,027 -13.1%
135.09
US$273,827
2,027 -13.1% 135.09 US$273,827
2020-09-14 2020-09-10 S Sale
3,036 -17.9%
89.31
US$271,145
3,036 -17.9% 89.31 US$271,145
2004-05-03 2003-12-03 B Purchase
5,000 +inf%
22.68
US$113,394
5,000 +inf% 22.68 US$113,394